ArticleMolecular and clinical oncology2015

Vascular endothelial growth factor receptor tyrosine kinase inhibitors versus bevacizumab in metastatic colorectal cancer: A systematic review and meta-analysis.

Zexin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.